FDA fast-tracks psychedelic drug research following Trump executive order
- Posted on April 24, 2026
- By CNBC
- 0 Views
- 1 min read
FDA fast-tracks psychedelic drug research following Trump executive order
It's a big shift toward supporting psychedelic-based medicines for treatment-resistant depression, PTSD and substance use disorders, the FDA said.
